Studies have shown that the activation of NOD2 can affect host immunity through multiple pathways (including the production and activation of CD8+ T cells, macrophages, and type 1 DCs) and improve the ICI response to eliminate tumor cells [46]. The gene discussed is CD8A; the disease is neoplasm.